Angle Share News (AGL)

Angle initiates 200 patient European ovarian cancer study

(ShareCast News) - Medical technology company Angle's European ovarian cancer study has been formally initiated with a first patient recruited. Angle completed the process required to initiate this study, which included optimising the system protocols for the application, development and approval of

Angle Recruits First Patient For European Ovarian Cancer Study

ANGLE Flags Parsortix System Traction At Manchester Conference

Sunday share tips: Purplebricks, Associated British Foods, Angle

(ShareCast News) - Purplebricks Group shares were a 'buy' in the Sunday Times' Inside the City column. Investing in this online estate agency might be a wild ride, with the shares trading for more than 40 times earnings, but some notable names are on the register since its IPO at the end of last yea

ANGLE Signs University Of Manchester Deal, Raises GBP10.2 Million (ALLISS)

ANGLE Gets Strong Results From Parsortix Breast Cancer Tests

Angle closer to using cassette tech for prostate cancer detection

(ShareCast News) - There was praise for the progress made by Angle on Monday, in its quest to see one of its existing products used as a diagnostic tool for prostate cancer. The AIM-traded company was the subject of a report by equity advisory firm Edison, which said that while the final data was ye

ANGLE Gets Good Results On Parsortix System Tests For Prostate Cancer

ANGLE Secures European Patent For Parsortix System

ANGLE First Half Loss Widens As It Continues Parsortix Development

ANGLE Says Parsortix Evaluation Published In Medical Journal

Angle Receives GBP700,000 From Geomerics Sale Escrow Release

ANGLE Secures First Commercial Sales For Parsortix Research System

ANGLE Says "Highly Encouraging" Parsortix Results Published

ANGLE Granted Canadian Patent For Parsoritx System